Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (441-450 of 475) with videos related to

Pageof 48
Sort By:
Urologic Oncology|March 7, 2021
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensusWei Phin Tan, Ardeshir R Rastinehad, Laurence Klotz, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
Radiology|April 3, 2019
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion CoefficientEdward W Johnston, Elisenda Bonet-Carne, Uran Ferizi, et al.
European Radiology|June 30, 2022
Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowshipFrancesco Giganti, Alexander P Cole, Fiona M Fennessy, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
Critical Reviews in Oncology/Hematology|August 11, 2012
Active surveillance for low-risk prostate cancerChris H Bangma, Meelan Bul, Theo H van der Kwast, et al.
Health Technology Assessment (Winchester, England)|July 25, 2018
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS studyLouise Clare Brown, Hashim U Ahmed, Rita Faria, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
JAMA Oncology|June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus RecommendationsNikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
European Urology|July 10, 2026
Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE RegistriesAlexander Light, Max Peters, Archana Gopalakrishnan, et al.
Pageof 48

Showing results (441-450 of 475) with videos related to

Sort By:
Pageof 48
Urologic Oncology|March 7, 2021
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensusWei Phin Tan, Ardeshir R Rastinehad, Laurence Klotz, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
Radiology|April 3, 2019
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion CoefficientEdward W Johnston, Elisenda Bonet-Carne, Uran Ferizi, et al.
European Radiology|June 30, 2022
Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowshipFrancesco Giganti, Alexander P Cole, Fiona M Fennessy, et al.
Prostate Cancer and Prostatic Diseases|May 2, 2021
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour controlMarieke J van Son, Max Peters, Deepika Reddy, et al.
Critical Reviews in Oncology/Hematology|August 11, 2012
Active surveillance for low-risk prostate cancerChris H Bangma, Meelan Bul, Theo H van der Kwast, et al.
Health Technology Assessment (Winchester, England)|July 25, 2018
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS studyLouise Clare Brown, Hashim U Ahmed, Rita Faria, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
JAMA Oncology|June 11, 2026
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus RecommendationsNikhil Mayor, Alexander Light, Archana Gopalakrishnan, et al.
European Urology|July 10, 2026
Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE RegistriesAlexander Light, Max Peters, Archana Gopalakrishnan, et al.
Pageof 48